glp-1 dual agonist Activity-balanced GLP-1/GDF15 reduces body weight and metabolic disorder in mice and non-human primates: Cell Metabolism Dual and Triple Gut Peptide

Phase III studies enrolled more than 1,400 patients and demonstrated that exenatide effectively lowered blood glucose while producing an unexpected but welcome side effect: weight loss

The best next step is speaking with a qualified medical provider who understands both medical weight loss and peptide-based wellness approaches

Ongoing support : We monitor your progress with follow-ups to optimize your results

That single interaction has downstream effects across several healing pathways: it supports stem-cell migration to injury sites, promotes angiogenesis (like BPC-157, but through a different mechanism), and dampens inflammatory signaling during the repair phase

Distributed by Peptides Lab UK in lyophilised format for controlled laboratory research